Chenguang Wang
0000-0002-9082-2117
University of Michigan
41 papers found
Refreshing results…
Supplementary Figure S2 from GATA-3–dependent Gene Transcription is Impaired upon HDAC Inhibition
Supplementary Table S3 from GATA-3–dependent Gene Transcription is Impaired upon HDAC Inhibition
Supplementary Table S1 from GATA-3–dependent Gene Transcription is Impaired upon HDAC Inhibition
Data from GATA-3–dependent Gene Transcription is Impaired upon HDAC Inhibition
Supplementary Figure S3 from GATA-3–dependent Gene Transcription is Impaired upon HDAC Inhibition
Supplementary Figure S1 from GATA-3–dependent Gene Transcription is Impaired upon HDAC Inhibition
Supplementary Table S2 from GATA-3–dependent Gene Transcription is Impaired upon HDAC Inhibition
GATA-3–dependent Gene Transcription is Impaired upon HDAC Inhibition
Data File DS1 from Targeting Lymphoma-associated Macrophage Expansion via CSF1R/JAK Inhibition is a Therapeutic Vulnerability in Peripheral T-cell Lymphomas
Data from Targeting Lymphoma-associated Macrophage Expansion via CSF1R/JAK Inhibition is a Therapeutic Vulnerability in Peripheral T-cell Lymphomas
Table TS1 from Targeting Lymphoma-associated Macrophage Expansion via CSF1R/JAK Inhibition is a Therapeutic Vulnerability in Peripheral T-cell Lymphomas
Fig. S6 from Targeting Lymphoma-associated Macrophage Expansion via CSF1R/JAK Inhibition is a Therapeutic Vulnerability in Peripheral T-cell Lymphomas
Fig. S4 from Targeting Lymphoma-associated Macrophage Expansion via CSF1R/JAK Inhibition is a Therapeutic Vulnerability in Peripheral T-cell Lymphomas
Fig. S5 from Targeting Lymphoma-associated Macrophage Expansion via CSF1R/JAK Inhibition is a Therapeutic Vulnerability in Peripheral T-cell Lymphomas
Fig. S1 from Targeting Lymphoma-associated Macrophage Expansion via CSF1R/JAK Inhibition is a Therapeutic Vulnerability in Peripheral T-cell Lymphomas
Fig. S2 from Targeting Lymphoma-associated Macrophage Expansion via CSF1R/JAK Inhibition is a Therapeutic Vulnerability in Peripheral T-cell Lymphomas
Fig. S3 from Targeting Lymphoma-associated Macrophage Expansion via CSF1R/JAK Inhibition is a Therapeutic Vulnerability in Peripheral T-cell Lymphomas
Fig. S7 from Targeting Lymphoma-associated Macrophage Expansion via CSF1R/JAK Inhibition is a Therapeutic Vulnerability in Peripheral T-cell Lymphomas
Data File DS2 from Targeting Lymphoma-associated Macrophage Expansion via CSF1R/JAK Inhibition is a Therapeutic Vulnerability in Peripheral T-cell Lymphomas
Data File DS3 from Targeting Lymphoma-associated Macrophage Expansion via CSF1R/JAK Inhibition is a Therapeutic Vulnerability in Peripheral T-cell Lymphomas
Missing publications? Search for publications with a matching author name.